Status:
UNKNOWN
Botulinum A Toxin in the Treatment of Patients With Painful Bladder Syndrome
Lead Sponsor:
University Of Perugia
Conditions:
Painful Bladder Syndrome (PBS)
Eligibility:
FEMALE
18-80 years
Phase:
PHASE4
Brief Summary
Previous clinical observations showed that Botulinum A toxin (BoNT/A) has also an antinociceptive effect and can control the neuropathic pain. In the urologic field, recent in in vitro and in in vivo...
Detailed Description
Patients with refractory PBS will be prospectively enrolled in the study. Baseline evaluation: Clinical evaluation with visual analog scale (VAS) for pain quantification; QoL assessment with a standar...
Eligibility Criteria
Inclusion
- refractory bladder pain, the urgency-frequency syndrome, and sterile urine
Exclusion
- neurological diseases
- pregnancy and concomitant use of aminoglycosides and anticoagulants
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01157507
Start Date
January 1 2010
End Date
September 1 2011
Last Update
April 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Perugia
Perugia, Perugia, Italy, 16100